Company intelligence / Profile preview

CPM Medical Consultants

Richardson, Texas, United States

Ownership: Private
Development stage: Other

Overview

CPM Medical Consultants manufactured the Tibial Revision Knee System, a Class II medical device cleared by the FDA in 2021 for use in revision knee replacement procedures, particularly for patients requiring augmentation, stem extensions, or constrained stabilization due to inadequate bone stock or soft tissue imbalance.

Therapeutic areas: Rheumatology
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

Progressive Orthopaedic Company (device compatibility)Modal Manufacturing (design partnership)United Orthopedic Corporation (predicate device reference)

Beyond the preview

Go deeper on CPM Medical Consultants.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CPM Medical Consultants.

Explore the full profile